Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | NSD2 | O96028 | 1/20 | 0.43 |
| ▸ | SSTR4 | P31391 | 4/20 | 0.42 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.42 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.42 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.42 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.42 |
| ▸ | FAP | Q12884 | 5/20 | 0.41 |
| ▸ | TACR3 | P29371 | 1/20 | 0.40 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.40 |
| ▸ | PREP | P48147 | 3/20 | 0.40 |
| ▸ | NR2E1 | Q9Y466 | 1/20 | 0.40 |
| ▸ | CTSB | P07858 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5271311 | 0.74 | NSD2 (0.52) | NSD2FAPPREPNR2E1HDAC3 | |
| SCHEMBL787527 | 0.74 | CXCR2 (0.46) | NSD2SSTR4FAPTACR3NR2E1 | |
| SCHEMBL8573837 | 0.72 | NSD2 (0.56) | NSD2FAPPREPNR2E1HDAC3 | |
| Hydrochloric Acid SCHEMBL28349289 | 0.71 | NSD2 (0.55) | NSD2FAPPREPNR2E1HDAC3 | |
| SCHEMBL9399457 | 0.71 | PTPN1 (0.51) | KDM4EHDAC3HDAC1HDAC7HDAC2 | |
| SCHEMBL25753495 | 0.71 | NSD2 (0.58) | KDM4ENSD2SSTR4HDAC6 | |
| SCHEMBL379808 | 0.70 | CYP3A4 (0.60) | NSD2NR2E1 | |
| SCHEMBL8240231 | 0.70 | NR2E1 (0.44) | KDM4ENSD2SSTR4FAPNR2E1 | |
| SCHEMBL5603305 | 0.70 | NSD2 (0.56) | KDM4ENSD2FAPPREPHDAC3 | |
| SCHEMBL28834556 | 0.69 | HDAC3 (0.58) | KDM4ENSD2FAPPREPNR2E1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9040553-B2 | Phenoxyisobutyric acid compounds and method of synthesis | Cell Viable Corporation (US) | 2015-05-26 | — | — | US | disclosed |
| US-20140350045-A1 | PHENOXYISOBUTYRIC ACID COMPOUNDS AND METHOD OF SYNTHESIS | LALEZARI IRAJ (US) | 2014-11-27 | — | — | US | disclosed |
| EP-2616430-A2 | NOVEL PHENOXYISOBUTYRIC ACID COMPOUNDS AND METHODS FOR SYNTHESIS | Cell Viable Corporation (US) | 2013-07-24 | — | — | EP | disclosed |
| WO-2012050623-A2 | NOVEL PHENOXYISOBUTYRIC ACID COMPOUNDS AND METHODS FOR SYNTHESIS | Cell Viable Corporation (US) | 2012-04-19 | — | — | WO | disclosed |
| US-20120071502-A1 | Novel phenoxyisobutyric acid compounds and methods for synthesis | Cell Viable Corporation (US) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140350045-A1 | PHENOXYISOBUTYRIC ACID COMPOUNDS AND METHOD OF SYNTHESIS | AGER, BPGM, PDXK | KDM4E 350/4885NSD2 4733/4885SSTR4 623/4885 |
| US-20120071502-A1 | Novel phenoxyisobutyric acid compounds and methods for synthesis | AGER, BPGM, PDXK | KDM4E 363/4885NSD2 4811/4885SSTR4 761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.